Atlas Trials

Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea

Clinical trial NCT01987765 · COMPLETED

Trial details

NCT number
NCT01987765
Sponsor
Allergan
Status
COMPLETED
Study type
OBSERVATIONAL
Conjunctivitis, Allergic
Start date
2009-01-01
Primary completion
2012-09-01
Enrollment
847

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.